...court has banned continued shipments of the generic, saying it infringed Plavix patents held by Bristol's marketing partner Sanofi-Aventis . Sales of HIV treatment Reyataz, helped by its convenient once-daily dosing, surged 28 percent to $324 million, while...

...new health-care trail by mixing its branded business with the acquisition of German generic provider Hexal in 2005, while Sanofi-Aventis is currently looking to buy Czech-based Zentiva to bolster its generic business. And back here at home, in a stunning recent...

...its experimental blood-thinner prasugrel in September. That drug will compete with Plavix, sold by Bristol-Myers and Sanofi-Aventis. In a research note, analysts at Argus Research said that in the long term, “Lilly’s earnings growth has the potential to accelerate,...

...Ratings Methodology Ratings Overview Weighting Sources Companies Mentioned: - Pfizer - Novartis - Sanofi-Aventis - GlaxoSmithKline - Merck & Co - Teva Pharmaceutical Industries - Taro - Perrigo (Agis Industries) - Dexcel - Trima...

...head of Sanofi-Aventis' German operations Heinz-Werner Meier will leave his post at the end of the year, Financial Times Deutschland reported, citing the company. Meier, a long-time executive at German drugs and chemicals maker Hoechst, which is now part of...

...on Japan's small but fast-growing market for generics, encouraged by the government's drive to reduce medicine costs. Sanofi-Aventis of France is bidding for control of Czech-based Zentiva, emphasising profits and important growth by generics in eastern and...

... Competitive Landscape Table: Top 10 Drugmakers In South Africa, 2006 Company Monitor Leading Foreign Companies Sanofi-Aventis Pfizer Roche GlaxoSmithKline Merck & Co Leading Indigenous Manufacturers Aspen Pharmacare Adcock Ingram ...

...from Merck this year. Global sales of Gardasil in the second quarter, including Europe through its joint venture with Sanofi-Aventis, increased 28 per cent to $US560 million, Merck said in its full-year results. Full-year sales are expected to reach $US1.4-1.6...

...National Notary Association, Organon/Schering-Plough (NYSE: SGP), Pfizer (NYSE: PFE), Procter & Gamble (NYSE: PG), Roche and Sanofi-Aventis (NYSE: SNY). For more information, visit www.safe-biopharma.org. SAFE-BioPharma(TM) is a trademark of SAFE-BioPharma...

...of Germany and merged it with its own Sandoz arm to create the world’s second-largest generics group in its own right. Sanofi-Aventis is currently bidding against a rival consortium to buy control of Zentiva, a Czech generic drugs manufacturer, as it expands...